gemcitabine,cisplatin,zandelisib
kyowa kirin,mei
[]
in anticipation of the #hpb day tomorrow #gi23, #cholangiocarcinoma trials were recently published 1 jcog1202, ascot os benefit of adjuvant s1 vs obs in resected btc 2 stamp os improvement with adjuvant gem/cis over cape in resected ln+ extrahepatic cc 
Hedinger Chair of Surgical Oncology at OHSU | Physician-in-Chief, Knight Cancer Institute | ASCO FCOI: https://t.co/IvPDoFMZZG